Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGEN Repligen Corporation

休市中 05-03 16:00:00 EDT

167.05

+0.74

+0.44%

盘后167.05

+0.000.00%

19:17 EDT

最高172.00	最低166.43	成交量45.50万
今开170.10	昨收166.31	日振幅3.35%
总市值93.28亿	流通市值86.89亿	总股本5,584万
成交额7,655万	换手率0.87%	流通股本5,201万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":167.05,"timestamp":1714766400000,"preClose":166.31,"halted":0,"volume":454984,"hourTrading":{"tag":"盘后","latestPrice":167.05,"preClose":167.05,"latestTime":"19:17 EDT","volume":24351,"amount":4067793.7774,"timestamp":1714778228635},"delay":0,"floatShares":52013199,"shares":55838548,"eps":0.264637,"marketStatus":"休市中","marketStatusCode":7,"change":0.74,"latestTime":"05-03 16:00:00 EDT","open":170.1,"high":172,"low":166.43,"amount":76546317.06672,"amplitude":0.033492,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.264637,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"adjPreClose":166.31,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":170,"preClose":166.31,"latestTime":"09:28 EDT","volume":301,"amount":51167.00204,"timestamp":1714742880041},"postHourTrading":{"tag":"盘后","latestPrice":167.05,"preClose":167.05,"latestTime":"19:17 EDT","volume":24351,"amount":4067793.7774,"timestamp":1714778228635},"volumeRatio":0.6931640347072004},"requestUrl":"/m/hq/s/RGEN","defaultTab":"news","newsList":[{"id":"2432570203","title":"Repligen 公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570203","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432570203?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:52","pubTimestamp":1714571577,"startTime":"0","endTime":"0","summary":"   * Repligen Corp   公布的截至三月份的季度调整后每股收益为28美分，低于去年同期的每股收益64美分。12 位分析师对该季度的平均预期是每股收益 30 美分。华尔街预期为每股收益 27 美分至 34 美分。* Repligen 公司公布的本季度每股收益为 4 美分。* 公司报告的季度净收入为 209 万美元。* Repligen Corp本季度股价下跌了10.7%，今年迄今为止下跌了8.7%。华尔街对 Repligen 公司 12 个月目标价的中位数为 215.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432770105","title":"Repligen Corporation盘中异动 早盘快速下跌6.18%报154.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432770105","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432770105?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:31","pubTimestamp":1714570282,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时31分，Repligen Corporation股票出现异动，股价大幅下挫6.18%。截至发稿，该股报154.06美元/股，成交量3.2838万股，换手率0.06%，振幅4.87%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.35%。其相关个股中，Predictive Oncology Inc.、Milestone Scientific, Inc.、Singular Genomics Systems, Inc.涨幅较大，Predictive Oncology Inc.、Repligen Corporation、Atrion较为活跃，换手率分别为76.81%、0.06%、0.05%，振幅较大的相关个股有Glucotrack, Inc.、Predictive Oncology Inc.、Repligen Corporation，振幅分别为7.79%、6.26%、4.87%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012131237a57db31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012131237a57db31&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431489912","title":"Repligen Corp    预计每股收益 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431489912","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431489912?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:33","pubTimestamp":1714404798,"startTime":"0","endTime":"0","summary":"   * Repligen公司   将于5月1日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆市的公司的营收将从去年同期的1.8266亿美元降至1.5062亿美元，降幅为17.8%。* LSEG分析师对Repligen公司的平均预期为每股收益30美分。* 华尔街对 Repligen Corp 的 12 个月目标价中位数为 215.00 美元，高于其上次收盘价 166.58 美元。4月29日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413420708","title":"嗡嗡声--美国股票走势-Toll Brothers、Natgas 公司、Eton 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2413420708","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413420708?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:55","pubTimestamp":1708530942,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月21日 - 华尔街周三下跌，因为投资者在等待芯片设计公司英伟达的高风险财报，如果财报不尽如人意，可能会阻碍今年的人工智能热潮。美东时间10:33，道琼斯工业平均指数  下跌0.24%，报38472.83点。标准普尔500指数  下跌0.26%，报4,962.55点；纳斯达克综合指数  下跌0.62%，报15,533.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":-0.0579},{"period":"3month","weight":-0.1484},{"period":"6month","weight":0.111},{"period":"1year","weight":0.0625},{"period":"ytd","weight":-0.0709}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约，并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品，这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验，公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究，弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外，公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.684211,"avgChangeRate":0.094555},{"month":2,"riseRate":0.421053,"avgChangeRate":0.031694},{"month":3,"riseRate":0.552632,"avgChangeRate":0.040702},{"month":4,"riseRate":0.473684,"avgChangeRate":-0.005601},{"month":5,"riseRate":0.589744,"avgChangeRate":0.053533},{"month":6,"riseRate":0.473684,"avgChangeRate":-0.009081},{"month":7,"riseRate":0.5,"avgChangeRate":0.023766},{"month":8,"riseRate":0.578947,"avgChangeRate":0.03293},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.040492},{"month":10,"riseRate":0.473684,"avgChangeRate":0.026608},{"month":11,"riseRate":0.447368,"avgChangeRate":0.027598},{"month":12,"riseRate":0.5,"avgChangeRate":-0.001659}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}